| Literature DB >> 28928314 |
Rumana Huque1, M Mostafa Zaman2, Syed Mahfuzul Huq3, Dhirendra N Sinha4.
Abstract
Despite the high prevalence of smokeless tobacco (SLT) use among adults in Bangladesh, SLT was not included in the Tobacco Control Law till 2013. Information on SLT use among Bangladeshi people is inadequate for policymaking and implementing effective control measures. With the aim to identify the prevalence and trends of different SLT products, health and economic impacts, manufacture, and sale of and policies related to SLT in Bangladesh, we carried out a literature review, which involved literature search, data extraction, and synthesis. Evidence suggests that in Bangladesh, SLTs range from unprocessed to processed or manufactured products including Sada Pata, Zarda, Gul, and Khoinee. Over 27% of Bangladeshi adults aged 15 years and older use SLT in one form or other. SLT use is associated with age, sex, education, and socioeconomic status. SLT consumption has reportedly been associated with increased prevalence of heart diseases, stroke, and oral cancer and led to around 320,000 disability adjusted life years lost in Bangladesh in 2010. No cessation service is available for SLT users in public facilities. Compared to cigarettes, taxation on SLT remains low in Bangladesh. The amendment made in Tobacco Control Law in 2013 requires graphic health warnings to cover 50% of SLT packaging, ban on advertisement of SLT products, and restriction to sale to minors. However, implementation of the law is weak. As the use of SLT is culturally accepted in Bangladesh, culturally appropriate public awareness program is required to curb SLT use along with increased tax and cessation services.Entities:
Mesh:
Year: 2017 PMID: 28928314 PMCID: PMC6349136 DOI: 10.4103/ijph.IJPH_233_17
Source DB: PubMed Journal: Indian J Public Health ISSN: 0019-557X
Popular smokeless tobacco products in Bangladesh: Ingredients, forms, and consumption
| SLT products[ | Ingredients[ | Form[ | Consumption[ | Prevalence (%) of SLT use among adults aged ≥15 years[ |
|---|---|---|---|---|
| Tobacco, lime, spices, vegetable dye, areca nut | Manufactured commercially | Chewed with betel leaf, lime, and areca nut | 24.3 | |
| Tobacco powder, molasses | Manufactured commercially | Applied to teeth and gum | 5.3 | |
| Sun-dried or cured raw tobacco leaf | Processed but unpacked | Chewed with betel leaf, lime, and areca nut | 1.8 | |
| Tobacco, slaked lime, menthol, flavorings, and areca nut | Manufactured commercially or prepared by user themselves | Kept in mouth between lips and gum | 1.5 | |
| Any form of SLT | Manufactured commercially, or processed but unpacked, or prepared by user | As above | 27.2 |
Adapted from Siddiqi et al., 2015; WHO, 2009. SLT: Smokeless tobacco
Prevalence (%) of smokeless tobacco usage estimated in different national level studies
| Indicator | Health cost study 2004 | STEPS 2006 | GATS 2009 | STEPS 2010 | STEPS 2013 |
|---|---|---|---|---|---|
| Percentage of men who use SLT | 14.8 | 24.1 | 26.4 | 29.4 | 28.5 |
| Percentage of women who use SLT | 24.4 | 34.2 | 27.9 | 33.6 | 29.5 |
| Percentage of men and women who use SLT | 19.7 | 28.6 | 27.2 | 31.7 | 28.7 |
SLT: Smokeless tobacco
Related risk and population attributable risk of diseases for smokeless tobacco usage from the hospital survey
| Diseases | Men | Women | ||
|---|---|---|---|---|
| Related risks | Population attributable risk (%) | Related risks | Population attributable risk (%) | |
| Ischemic heart disease | 2.6 | 32.5 | 1.7 | 22.6 |
| Stroke | 2.1 | 23.8 | 2.6 | 41.2 |
| Buerger’s disease | 1.8 | 16.1 | Negligible | Negligible |
| Oral cancer | 4.9 | 48.1 | 4.7 | 59.3 |
| Lung cancer | 1.2 | 3.9 | 12.6 | 82.7 |
| Laryngeal cancer | 1.5 | 10.2 | 7.8 | 73.1 |
| Chronic obstructive pulmonary disease | 1.7 | 15.0 | 1.8 | 24.6 |
| Pulmonary tuberculosis | 1.9 | 18.8 | 3.5 | 51.0 |
| All | 1.5 | 12.9 | 2.0 | 33.1 |
Source: WHO, 2009
Tax on smokeless tobacco in Bangladesh
| Year | Tax on SLT | Total (%) | Total tax collection from VAT and SD (million Taka) | ||
|---|---|---|---|---|---|
| SD (%) | VAT (%) | Health development surcharge (%) | |||
| 2010-2011 | 20 | 15 | - | 35 | 57.2 |
| 2011-2012 | 30 | 15 | - | 45 | 79.5 |
| 2012-2013 | 30 | 15 | - | 45 | 87.5 |
| 2013-2014 | 30 | 15 | - | 45 | 106.3 |
| 2014-2015 | 60 | 15 | 1 | 76 | 175.5 |
| 2015-2016 | 60 | 15 | 1 | 76 | 69.2 (up to October, 2015) |
| 2016-2017 | 100 | 15 | 1 | 116 | |
The tax base is ex-factory price. SD: Supplementary duty, SLT: Smokeless tobacco, VAT: Value added tax